The Patent Finder

Aspeya US Inc.

18 patents currently held · Updated Nov 15, 2026
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
0
Ending by 2030
Mar 2033
Next term end

When these terms end

Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045

Fee deadlines

Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
  • 1 fee due May 21, 2027
    The maintenance fee for Treating inflammation with inhaled aspirin (US 11,819,569) comes due May 21, 2027. Unpaid by Nov 22, 2027, it lapses early.
  • 1 fee due Jul 9, 2027
    The maintenance fee for Dry powder formulations and methods of use (US 11,865,210) comes due Jul 9, 2027. Unpaid by Jan 10, 2028, it lapses early.
  • 1 fee due Aug 25, 2027
    The maintenance fee for Dry powder formulations for inhalation (US 10,568,894) comes due Aug 25, 2027. Unpaid by Feb 25, 2028, it lapses early.

Which patents, and when each one lapses · Pro

Recent changes

Nothing was recorded against this company's patents in the last 90 days.

Patents held now

Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
PatentTitleStatus Expires Confidence
US 12,329,899Dry powder inhaler and methods of use
In force
 · From the USPTO record
In forceFrom the USPTO record
US 10,149,823Dry powder formulations and methods of use
In force
 · From the USPTO record
In forceFrom the USPTO record
US 11,819,569Treating inflammation with inhaled aspirin
In force
 · From the USPTO record
In forceFrom the USPTO record
US 11,865,210Dry powder formulations and methods of use
In force
 · From the USPTO record
In forceFrom the USPTO record
US 9,757,395Dry powder inhaler and methods of use
In force
 · From the USPTO record
In forceFrom the USPTO record
US 9,757,529Dry powder inhaler and methods of use
In force
 · From the USPTO record
In forceFrom the USPTO record
US 9,993,488Dry powder formulations for inhalation
In force
 · From the USPTO record
In forceFrom the USPTO record
US 10,772,832Dry powder formulations for inhalation
In force
 · From the USPTO record
In forceFrom the USPTO record
US 12,343,425Dry powder formulations for inhalation
In force
 · From the USPTO record
In forceFrom the USPTO record
US 11,596,603Dry Powder Formulations for Inhalation
In force
 · Low confidence
In forceLow confidence
10 of 18 patents shown.
Pro members see all 18.
Pro members: see all 18 patents

Sources and methods

Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited